Halozyme Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
12 Jun 24 | SellUS$1,006,300 | Matthew Posard | Individual | 20,000 | US$50.62 | |
14 Aug 23 | SellUS$874,520 | James Daly | Individual | 20,000 | US$43.74 |
Insider Trading Volume
Insider Buying: HALO insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 4,046 | 0.00318% |
State or Government | 48,164 | 0.0378% |
General Public | 1,060,348 | 0.833% |
Individual Insiders | 1,298,534 | 1.02% |
Institutions | 124,862,908 | 98.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
18,241,548 | US$927.8m | -2.09% | 0.02% | |||
13,049,253 | US$663.7m | -1.59% | 0.01% | |||
6,487,303 | US$329.9m | 0.18% | 0.01% | |||
4,117,227 | US$209.4m | 11% | 4.39% | |||
3,791,230 | US$192.8m | -43.3% | 0.16% | |||
3,666,324 | US$186.5m | 5.85% | 0.06% | |||
3,027,384 | US$154.0m | 3.69% | 0.01% | |||
2,991,125 | US$152.1m | -8.88% | 0.17% | |||
2,584,308 | US$131.4m | -5.35% | 0.02% | |||
2,541,266 | US$129.2m | 28.1% | 0.1% | |||
2,196,877 | US$111.7m | -1.33% | 0.99% | |||
1,858,841 | US$94.5m | 17.9% | 1.11% | |||
1,819,829 | US$92.6m | 0.41% | 0.02% | |||
1,791,904 | US$91.1m | -9.21% | 0.01% | |||
1,714,844 | US$87.2m | -10.8% | 0.16% | |||
1,688,229 | US$85.9m | 4.66% | 0.01% | |||
1,667,479 | US$84.8m | -3.95% | 0.01% | |||
1,546,666 | US$78.7m | 1.86% | 1.07% | |||
1,481,281 | US$75.3m | 6.75% | 0.02% | |||
1,433,612 | US$72.9m | 23.3% | 0.1% | |||
1,298,844 | US$66.1m | -6.55% | 0.01% | |||
1,215,769 | US$61.8m | 0% | 0.01% | |||
1,203,716 | US$61.2m | -6.2% | 0.01% | |||
1,194,464 | US$60.8m | 1,200% | 0.05% | |||
956,054 | US$48.6m | 107% | 0.01% |